Here, we found that silencing β-catenin deprived the ability of DVL3 to induce EMT-like molecular changes and stem cell marker expression, indicating that DVL3 triggered Wnt/β-catenin signaling to drive EMT and CSLCs of CRC. Here, DVL3 is linked to colorectal carcinoma.